Log in
Enquire now

List of Diffusion Pharmaceuticals patents

List of Diffusion Pharmaceuticals patents
List of Pharmacia & Upjohn patents
List of Illumio patents
List of Ginger.io patents
Bioinformatics venture capital investors
List of funding rounds for Joywell Foods
Patents where
Current Assignee
Name
is
Diffusion PharmaceuticalsDiffusion Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 11278621 Trans carotenoids, their synthesis, formulation and uses

Patent 11278621 was granted and assigned to Diffusion Pharmaceuticals on March, 2022 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11278621
March 22, 2022
‌
US Patent 10016384 Oral formulations of bipolar trans carotenoids

Patent 10016384 was granted and assigned to Diffusion Pharmaceuticals on July, 2018 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10016384
July 10, 2018
‌
US Patent 11491129 Oral formulations of bipolar trans carotenoids

Patent 11491129 was granted and assigned to Diffusion Pharmaceuticals on November, 2022 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11491129
November 8, 2022
‌
US Patent 8974822 Oral formulations of bipolar trans carotenoids

Patent 8974822 was granted and assigned to Diffusion Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8974822
March 10, 2015
‌
US Patent 11185523 Use of bipolar trans carotenoids with chemotherapy and radiotherapy for treatment of cancer

Patent 11185523 was granted and assigned to Diffusion Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11185523
November 30, 2021
‌
US Patent 9950067 Trans carotenoids, their synthesis, formulation and uses

Patent 9950067 was granted and assigned to Diffusion Pharmaceuticals on April, 2018 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9950067
April 24, 2018
‌
US Patent 7919527 Bipolar trans carotenoid salts and their uses

Patent 7919527 was granted and assigned to Diffusion Pharmaceuticals on April, 2011 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7919527
April 5, 2011
‌
US Patent 8030350 Trans carotenoids, their synthesis, formulation and uses

Patent 8030350 was granted and assigned to Diffusion Pharmaceuticals on October, 2011 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8030350
October 4, 2011
‌
US Patent 11147859 Diffusion enhancing compounds and their use alone or with thrombolytics

Patent 11147859 was granted and assigned to Diffusion Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11147859
October 19, 2021
‌
US Patent 8901174 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease

Patent 8901174 was granted and assigned to Diffusion Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8901174
December 2, 2014
‌
US Patent 8206751 Class of therapeutics that enhance small molecule diffusion

Patent 8206751 was granted and assigned to Diffusion Pharmaceuticals on June, 2012 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8206751
June 26, 2012
‌
US Patent 7351844 Bipolar trans carotenoid salts and their uses

Patent 7351844 was granted and assigned to Diffusion Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7351844
April 1, 2008
‌
US Patent 10130689 Diffusion enhancing compounds and their use alone or with thrombolytics

Patent 10130689 was granted and assigned to Diffusion Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10130689
November 20, 2018
‌
US Patent 9604899 Bipolar trans carotenoid salts and their uses

Patent 9604899 was granted and assigned to Diffusion Pharmaceuticals on March, 2017 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9604899
March 28, 2017
‌
US Patent 7759506 Bipolar trans carotenoid salts and their uses

Patent 7759506 was granted and assigned to Diffusion Pharmaceuticals on July, 2010 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
7759506
July 20, 2010
‌
US Patent 8017653 Bipolar trans carotenoid salts and their uses

Patent 8017653 was granted and assigned to Diffusion Pharmaceuticals on September, 2011 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8017653
September 13, 2011
‌
US Patent 8293804 Use of bipolar trans carotenoids as a pretreatment and in the treatment of peripheral vascular disease

Patent 8293804 was granted and assigned to Diffusion Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8293804
October 23, 2012
‌
US Patent 8269027 Bipolar trans carotenoid salts and their uses

Patent 8269027 was granted and assigned to Diffusion Pharmaceuticals on September, 2012 by the United States Patent and Trademark Office.

Diffusion Pharmaceuticals
Diffusion Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8269027
September 18, 2012
18 results
0 selected
18 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us